Cooperation agreement between Boehringer Ingelheim and Tsinghua University (Beijing)

Boehringer Ingelheim and Tsinghua University (Beijing) have jointly announced a scientific partnership aimed at developing new immunotherapies for the treatment of infectious diseases. The research will be conducted by scientists from both parties, in the new Boehringer Ingelheim-Tsinghua University Joint Research Center for Immuno-Infection. The initiative proves that the Germany-based company seeks to expand its business activity in the Chinese pharmaceutical market, which now ranks second in the world.

(Source: Boehringer Ingelheim)